Cytokinetics Eulerpool Nyheter

Cytokinetics Aktiens nyheter

Cytokinetics bevakas av många journalister och investerare över hela världen. De senaste Cytokinetics nyheterna samlar vi här.

• 20 december ·

  Yahoo
  Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China
• 19 december ·

  Yahoo
  Calculating The Fair Value Of Cytokinetics, Incorporated (NASDAQ:CYTK)
• 6 december ·

  Yahoo
  Why Is Cytokinetics (CYTK) Down 9.7% Since Last Earnings Report?
• 3 december ·

  Yahoo
  Sector Update: Health Care Stocks Mixed Late Afternoon
• 3 december ·

  Yahoo
  Cytokinetics Announces Start of COMET-HF, a Confirmatory Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients with Symptomatic Heart Failure with Severely Reduced Ejection Fraction
• 2 december ·

  Yahoo
  Cytokinetics to Participate in December Investor Conferences
• 2 december ·

  Yahoo
  Cytokinetics Announces FDA Acceptance of New Drug Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy
• 2 december ·

  Yahoo
  Novocure device succeeds in pancreatic cancer study; FDA sets Cytokinetics decision date
• 22 november ·

  Yahoo
  Cytokinetics price target raised to $103 from $99 at Mizuho
• 21 november ·

  Yahoo
  Why Is Cytokinetics, Incorporated (CYTK) Among the Worst Performing Biotech Stocks in 2024?